Allen Feng is the founder of HebeCell. HebeCell has raised $10M in total funding. Latest round: Pre-Series A. Backed by Aceso Biotech Venture Fund.
Allen Feng is the CSO of HebeCell, a Delaware corporation founded in 2016. The company develops a patented scalable natural killer (NK) cell platform technology for applications in immune-oncology, viral infectious diseases, and autoimmune diseases. HebeCell raised $10 million in Pre-Series A financing in April 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library